CMT CORE MOLDING TECHNOLOGIES INC
Plastics Products, NEC · NYSE · SEC CIK 1026655 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY9.4%
TTM net income YoY-13.5%
TTM EPS YoY-13.8%
Revenue 3-yr CAGR-8.2%
Net income 3-yr CAGR-32.8%
Margins
Gross margin17.3%
Operating margin2.9%
Net margin2.4%
FCF margin-6.7%
EBITDA margin6.7%
Returns
ROE4.4%
ROA3.1%
ROIC (approx.)4.7%
Asset turnover1.27x
Leverage & solvency
Liabilities / assets30.2%
Debt / equity0.00x
Current ratio1.86x
Interest coverage49.05x
Cash quality & payout
Operating cash flow / net income1.20x
Accruals ratio-0.6%
Payout ratio—
Capex / revenue9.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20232024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $273.80M | $302.38M |
| Cost of revenue | $226.22M | $249.12M |
| Gross profit | $47.58M | $53.26M |
| R&D expense | $1.40M | $1.90M |
| SG&A expense | $33.36M | $36.56M |
| Operating income | $14.22M | $16.70M |
| Interest expense | $1,000 | -$193,000 |
| Pretax income | $14.68M | $17.48M |
| Income tax | $3.48M | $4.18M |
| Net income | $11.20M | $13.30M |
| EBITDA | $26.57M | $30.09M |
| EPS (basic) | 1.31 | 1.53 |
| EPS (diluted) | 1.29 | 1.51 |
| Weighted avg. shares (diluted) | 8.70M | 8.79M |
| Balance sheet | ||
| Cash & equivalents | $38.06M | $41.80M |
| Receivables | $30.83M | $30.12M |
| Inventory | $19.71M | $18.35M |
| Current assets | $103.33M | $102.89M |
| PP&E, net | $86.94M | $80.81M |
| Goodwill | $17.38M | $17.38M |
| Intangibles | $3.48M | $4.43M |
| Total assets | $228.13M | $209.55M |
| Current liabilities | $34.17M | $36.71M |
| Short-term debt | $2.08M | $1.81M |
| Long-term debt | $17.64M | $19.71M |
| Total debt | $19.71M | $21.52M |
| Total liabilities | $69.96M | $62.19M |
| Shareholders' equity | $158.17M | $147.36M |
| Net debt | -$18.34M | -$20.28M |
| Shares outstanding | 8.51M | 8.61M |
| Cash flow statement | ||
| Operating cash flow | $19.18M | $35.15M |
| Capital expenditure | $17.27M | $11.53M |
| Free cash flow | $1.92M | $23.63M |
| Investing cash flow | -$17.27M | -$11.53M |
| Financing cash flow | -$5.66M | -$5.93M |
| Depreciation & amortization | $12.35M | $13.40M |
| Stock-based compensation | $1.79M | $2.50M |
| Share buybacks | $3.17M | $2.94M |
Free plan shows the latest 2 periods; Pro shows all 16 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.